Envirotainer
A global provider of mission critical biopharma transport services.
Envirotainer is a global market leader in mission critical temperature controlled supply chain solutions for the transportations of biopharmaceuticals.
- Sector
Healthcare
- Country
Sweden
- Fund
EQT X
- Entry
2022
Responsible Advisor
Ali Farahani
Website
About Envirotainer
Envirotainer was established in 1985 and is headquartered in Stockholm, Sweden. The company is a global market leader in air transport of temperature sensitive pharmaceuticals. With the world's largest fleet of specialized containers and close collaboration with airlines and freight forwarders, Envirotainer meets the pharmaceutical industry's complex need for fast and safe cold chain shipments where the pharmaceutical maintains exactly the right temperature throughout transport - from factory to end user.
Biological drugs are very temperature sensitive and large values are lost every year due to shortcomings in the logistics chain. Envirotainer's solutions provide the opportunity to meet complex and regulatory requirements when transporting these medicines under controlled temperatures. Thus, the company has a key role to play in ensuring that vital treatments, such as vaccines, insulin and oncological drugs, reach patients safely. Envirotainer delivered two million doses of medication every day in 2021.
Market trends and drivers
Envirotainer is uniquely positioned as the market leader and industry gold standard, in a highly attractive, resilient and strongly growing niche market with exposure to the underlying biopharma market. The market growth is supported by secular trends such as growing and aging global population, stricter pharma regulatory requirements and innovation of pharma products requiring cold chain solutions.
Millions of people across the globe depend on the safe delivery of biopharmaceuticals that require temperature control to maintain their integrity and quality. Today, lack of access to medicines is a cause for distress that disproportionately impacts underserved communities, whose situation is likely to be exacerbated by chronic diseases resulting from changing diets and lifestyles, as well as from air and water pollution. Envirotainer expands access to vital pharmaceuticals and vaccines through its patient-safe, reliable and efficient cold chain solutions, which also offer one of the lowest carbon footprint solutions in the industry.
Investment potential
EQT Private Equity will support Envirotainer in its next phase of growth by accelerating expansion in APAC and further driving growth in its other core markets, while investing behind new technology innovations, digitalization and sustainability in its operations.
Board of directors
Chairperson
Jarl Dahlfors
Board member
Ali Farahani
Board member
Simon Tillmo
Board member
Andreas Säther
Union representative
Andreas Jacobsson
Board member
Tom Thomasson
Board member
Wes Wheeler
Board member
Linzell Harris
Board member
Margaret Rumpf
Board member
Mina Abdulla Hamoodi
Management
CEO
David Simonsson
COO
Niklas Adamsson
CFO
Martin Hamner
CHRO
Molly Söderström Högling
CTO
Camilla Engbrink
CCO
Delphine Perridy
Do You Want to Know More?
We are eager to explore how we can achieve great things together.